PG
51
3
TXT
58
-2
CF
57
-3
CVS
45
-4
EXPD
53
-3
CMA
62
-2
LYB
46
-4
TXN
50
-3
L
55
-4
PCG
80
3
OMC
64
-2
SIG
57
-3
RSG
59
2
CCL
68
-4
VMC
57
-3
OI
43
-7
NTAP
60
2
EMC
53
-3
AN
50
-5
PYPL
43
-4
PG
51
3
TXT
58
-2
CF
57
-3
CVS
45
-4
EXPD
53
-3
CMA
62
-2
LYB
46
-4
TXN
50
-3
L
55
-4
PCG
80
3
OMC
64
-2
SIG
57
-3
RSG
59
2
CCL
68
-4
VMC
57
-3
OI
43
-7
NTAP
60
2
EMC
53
-3
AN
50
-5
PYPL
43
-4
Financhill
Back

SPDR® FactSet Innovative Technology ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
73

XITK
SPDR® FactSet Innovative Technology ETF

Last Price:
153.20
Seasonality Move:
0.7%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
73
SPDR® FactSet Innovative Technology ETF (XITK) is a Buy

Is SPDR® FactSet Innovative Technology ETF a Buy, Sell or Hold?

  • The current SPDR® FactSet Innovative Technology ETF [XITK] share price is $152.77. The Score for XITK is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • XITK is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

XITK Stock Price Chart

What is SPDR® FactSet Innovative Technology ETF's stock price today?

  • The SPDR® FactSet Innovative Technology ETF share price today is $152.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XITK is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

XITK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.26 Buy
Relative Strength Index (14 RSI): 62.93 Buy
Chaikin Money Flow: 1058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (144.8 - 151.56) Buy
Bollinger Bands (100): (140.97 - 149.77) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

XITK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 149.21 Buy
20-day SMA: 147.83 Buy
50-day SMA: 146.68 Buy
200-day SMA: 145.2 Buy
8-day EMA: 149.66 Buy
20-day EMA: 147.9 Buy
50-day EMA: 146.67 Buy
200-day EMA: 142.62 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

SPDR® FactSet Innovative Technology ETF Earnings Growth & XITK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

SPDR® FactSet Innovative Technology ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):